Finnhub•2026-04-17
Omada Health Announces New Study Results for GLP-1 Care TrackOMDA — Omada Health Inc
NASDAQ · Health Care · Health Care
$14.29-6.66%Market cap763.67M
- Latest Close
- $14.29
- 30-Day Move
- -6.7%
- Market Cap
- $764M
- Shares Outstanding
- 58,930,000
- P/B Ratio
- 3.98
- ROE
- -5.6%
Analyst consensus: Buy · 17 analysts
NASDAQ:OMDAHealth Care / Health CareDelayed public snapshot
Omada Health Inc
A read-only Alphactor snapshot forOmada Health Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-21
Topline snapshot
Latest Close
$14.29
30-Day Move
-6.7%
Market Cap
$764M
Shares Outstanding
58,930,000
P/B Ratio
3.98
ROE
-5.6%
Not investment advice. Signals and scores shown here are model outputs derived from historical data, not recommendations. Past performance does not guarantee future results. Do your own research before trading. Full disclaimer
Chart snapshot
$14.29
-6.7%last 90 delayed daily bars
Market cap$764M
90D High
$17.27
90D Low
$10.28
Avg Volume
1,209,716
What stands out
Gross margin is running at 65.7%, which gives a quick read on operating quality before you open the full model.
Net margin is -4.9%, useful for comparing OMDA against peers in Health Care.
OMDA is down 6.7% over the last 30 trading days shown on this page.
Latest operating income is $3M, which helps anchor the headline ratios with an actual earnings figure.
Research snapshot
Composite Fair Value
$21.39
Rule of 40
58.0%
Dark Pool Short %
42.6%
Fundamentals snapshot
Latest Close
$14.29
30-Day Move
-6.7%
Market Cap
$764M
Shares Outstanding
58,930,000
P/B Ratio
3.98
ROE
-5.6%
ROA
-4.2%
Gross Margin
65.7%
Operating Margin
-5.4%
Net Margin
-4.9%
Debt / Equity
0
Current Ratio
3.6
Latest Revenue
$76M
Financial statement snapshot
Revenue
$76M
Gross Profit
$54M
Operating Income
$3M
Net Income
$5M
Gross Margin
6569.0%
Net Margin
-491.0%
Current Ratio
3.60
Debt / Equity
0.00
Valuation snapshot
Fair Value
$21.39
Upside / Downside
+49.7%
Signal
Undervalued
Implied Growth
18.1%
DCF
$16.93
EV/Rev
$25.85
Growth Assumption
42.9%
Discount Rate
9.6%
Terminal Growth
2.0%
Base FCF
$12M
Valuation spread
Current Price
$14.29
Composite Fair Value
$21.39
DCF
$16.93
EV/Rev
$25.85
After signup
The full valuation workspace goes deeper
Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.
Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.
Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.
Moderate growth priced in
Quality snapshot
Altman Z
5.45
Safe
Piotroski
7
Strong (7-9)
Cash Conversion
-1.43x
Rule of 40
58.0%
Strong
Annual financial history
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $89M | $-72M | $-73M | $-72M |
| 2023-12-31 | $123M | $-66M | $-68M | $-53M |
| 2024-12-31 | $170M | $-44M | $-47M | $-38M |
| 2025-12-31 | $260M | $-12M | $-13M | $12M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
News snapshot
Benzinga•2026-04-17
Omada Health Announces New Study Results Showing That Members In Its GLP-1 Care Track Lost An Average Of 1.8x More Total Weight And Reduced Their Body Fat Percentage Twice As Much Versus The Comparison GroupFinnhub•2026-04-17
Omada Health Helps Members on GLP‑1s Lose More Fat, Preserve Muscle Mass, and Improve Mental Health, New Study FindsFinnhub•2026-04-16
Omada Health to Announce First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026After signup
The full sentiment workspace adds context
Go past the public headlines into fuller article history, source cross-checks, and deeper narrative tracking.
Tie news into alerts, watchlists, and conviction changes instead of browsing one static batch of stories.
Insider activity snapshot
Buy Value
$0
Sell Value
$5M
Buys
0
Sells
10
Buy Value
$0
Sell Value
$5M
Buy/Sell Ratio
0.00x
After signup
The full app goes deeper on insider behavior
Inspect longer insider history, recurring buyers and sellers, and the broader transaction context beyond this snapshot.
Continue into deeper institutional and alternative-data views once you sign up.
Recent insider transactions
| Date | Name | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-08 | Shao Wei-Li | Sell | 2,829 | $12.71 |
| 2026-04-05 | Klapstein Julie D | A | 698 | $0.00 |
| 2026-04-05 | ROOT JONATHAN D | A | 882 | $0.00 |
| 2026-04-05 | HILLEMAN JERYL L | A | 1,544 | $0.00 |
| 2026-04-05 | FETTER TREVOR | A | 955 | $0.00 |
| 2026-03-13 | Cook Steven L. | Sell | 1,884 | $13.94 |
| 2026-03-09 | Duffy Sean P. | Sell | 200 | $14.88 |
| 2026-03-09 | Duffy Sean P. | Sell | 3,863 | $14.32 |
ETF holders snapshot
| ETF | Shares | Weight | As Of |
|---|---|---|---|
| LOOMIS SAYLES FUNDS II-Loomis Sayles Small Cap Growth Fund | 1,027,390 | 0.02% | 2025-12-31 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 1,008,543 | 0.02% | 2026-02-28 |
| Fidelity Select PORT.s-Select Medical Technology and Devices PORT. | 1,000,000 | 0.02% | 2026-02-28 |
| American Century Mutual Funds, Inc.-Small Cap Growth Fund | 921,607 | 0.02% | 2026-01-31 |
| Fidelity Select Portfolios-Select Health Care Portfolio | 850,000 | 0.01% | 2026-02-28 |
| Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund | 500,000 | 0.01% | 2026-01-31 |
| Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund | 450,000 | 0.01% | 2026-02-28 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 279,251 | 0.00% | 2025-12-31 |
After signup
The deeper ownership view shows who is leaning in
Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.
Use those ownership shifts alongside conviction and alerts in the full app workflow.
Institutional holders snapshot
FMR LLC (Fidelity)
Filed 2026-02-17
$82M
+5.4%
Citadel Advisors
Filed 2026-02-17
$20M
--
Vanguard Group
Filed 2025-11-07
$11M
+642.8%
Geode Capital Management
Filed 2025-11-12
$6M
+625.5%
Qube Research & Technologies
Filed 2026-02-17
$4M
--
Goldman Sachs
Filed 2026-02-10
$4M
-19.9%
Marshall Wace
Filed 2026-02-13
$3M
--
Renaissance Technologies
Filed 2026-02-12
$2M
+1042.4%
Dark-pool activity snapshot
Analyst consensus?
Rating(?)
3.94
Consensus
BuyTarget Mean(?)
—
Target High(?)
—
Target Low(?)
—
Analysts
17
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Healthcare Investing: Pharma, Biotech, and the FDA Calendar
A framework for navigating healthcare stocks across pharma, biotech, and medical devices, with emphasis on regulatory catalysts and pipeline valuation.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.